» Articles » PMID: 22134773

In Vitro Expansion of Human Glioblastoma Cells at Non-physiological Oxygen Tension Irreversibly Alters Subsequent in Vivo Aggressiveness and AC133 Expression

Overview
Journal Int J Oncol
Specialty Oncology
Date 2011 Dec 3
PMID 22134773
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Among markers of glioblastoma initiating cells, AC133 has been shown to be associated with glioblastoma resistance and malignancy. Recently, it was demonstrated that increasing oxygen tension (pO2) down-regulated AC133 expression in glioblastoma cells in vitro. In order to better understand extrinsic factor regulation of AC133, this work aimed to investigate the relationship between cell culture pO2, AC133 expression, and tumor development and phenotype. Using treatments with CoCl2 and HIF-1α shRNA knockdowns on non-sorted human primary glioblastoma cells cultured at low (3%) versus high (21%) oxygen tension, we established a responsibility for low pO2 in the maintenance of high levels of AC133 expression, with a major but non-exclusive role for HIF-1α. We also demonstrated that human glioblastoma cells previously cultured under high oxygen tension can lose part of their aggressiveness when orthotopically engrafted in SCID mice or lead to tumors with distinct phenotypes and no re-expression of AC133. These observations showed that the specific pO2 microenvironment irreversibly impacts glioblastoma cell phenotypes, highlighting the pertinence of culture conditions when extrapolating data from xenogenic models to human cells in their source environment. They also raised AC133 as a marker of non-exposure to oxygenated areas rather than a marker of aggressiveness or low pO2 niches.

Citing Articles

Preservation of the Hypoxic Transcriptome in Glioblastoma Patient-Derived Cell Lines Maintained at Lowered Oxygen Tension.

Gozdz A, Wojtas B, Szpak P, Szadkowska P, Czernicki T, Marchel A Cancers (Basel). 2022; 14(19).

PMID: 36230775 PMC: 9564145. DOI: 10.3390/cancers14194852.


A role for ceruloplasmin in the control of human glioblastoma cell responses to radiation.

Roy C, Avril S, Legendre C, Lelievre B, Vellenriter H, Boni S BMC Cancer. 2022; 22(1):843.

PMID: 35918659 PMC: 9347084. DOI: 10.1186/s12885-022-09808-6.


Preclinical Evaluation of Sodium Selenite in Mice: Toxicological and Tumor Regression Studies after Striatum Implantation of Human Glioblastoma Stem Cells.

Larrouquere L, Berthier S, Chovelon B, Garrel C, Vacchina V, Paucot H Int J Mol Sci. 2021; 22(19).

PMID: 34638987 PMC: 8508933. DOI: 10.3390/ijms221910646.


Perfluorocarbon-Loaded Lipid Nanocapsules to Assess the Dependence of U87-Human Glioblastoma Tumor pO2 on In Vitro Expansion Conditions.

Lemaire L, Nel J, Franconi F, Bastiat G, Saulnier P PLoS One. 2016; 11(10):e0165479.

PMID: 27788227 PMC: 5082913. DOI: 10.1371/journal.pone.0165479.


Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenografts.

Bhadury J, Einarsdottir B, Podraza A, Olofsson Bagge R, Stierner U, Ny L Oncotarget. 2016; 7(17):23801-11.

PMID: 27009863 PMC: 5029664. DOI: 10.18632/oncotarget.8181.


References
1.
Bao S, Wu Q, McLendon R, Hao Y, Shi Q, Hjelmeland A . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756-60. DOI: 10.1038/nature05236. View

2.
Lillien L, Raphael H . BMP and FGF regulate the development of EGF-responsive neural progenitor cells. Development. 2000; 127(22):4993-5005. DOI: 10.1242/dev.127.22.4993. View

3.
Panchision D . The role of oxygen in regulating neural stem cells in development and disease. J Cell Physiol. 2009; 220(3):562-8. DOI: 10.1002/jcp.21812. View

4.
Vaupel P, Kelleher D, Hockel M . Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol. 2001; 28(2 Suppl 8):29-35. DOI: 10.1016/s0093-7754(01)90210-6. View

5.
Miraglia S, Godfrey W, Yin A, Atkins K, Warnke R, HOLDEN J . A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood. 1998; 90(12):5013-21. View